Literature DB >> 2060201

Osteonecrosis of the femoral head. A prospective randomized treatment protocol.

B N Stulberg1, A W Davis, T W Bauer, M Levine, K Easley.   

Abstract

Conservative treatment versus core decompression for cases of osteonecrosis (ON) of the femoral head was prospectively reviewed in 36 patients. A preoperative evaluation of the patients' history, physical examination, Harris Hip Score, roentgenograms, computed tomography, bone scan, magnetic resonance imaging, and measurement of the intraosseous pressure was used to grade the level of ON according to a rating system developed by Ficat. Hips were randomized to core decompression or conservative treatment groups. Fifty-five hips in 36 patients were randomized (29 surgical and 26 conservative). When success was gauged by Harris Hip Scores for Stage I hips, treatment was successful for seven of ten (70%) operatively treated hips and one of five (20%) non-operatively treated hips. Among Stage II hips, treatment was successful for five of seven (71%) decompressed hips and none of seven conservatively treated hips. Successful treatment was accomplished in eight of 11 hips (73%) and one of ten hips (10%) in decompression and conservative groups, respectively, for Stage III hips. Stages 0 and IV had groups too small for comparison. Less successful results were seen if roentgenographic criteria of success were used. Survival analysis showed more favorable results with surgical treatment. Core decompression produced better results than conservative treatment in the early stages of ON.

Entities:  

Mesh:

Year:  1991        PMID: 2060201

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  41 in total

1.  Untreated asymptomatic hips in patients with osteonecrosis of the femoral head.

Authors:  Byung-Woo Min; Kwang-Soon Song; Chul-Hyun Cho; Sung-Moon Lee; Kyung-Jae Lee
Journal:  Clin Orthop Relat Res       Date:  2008-03-08       Impact factor: 4.176

Review 2.  Orthopedic surgery and its complication in systemic lupus erythematosus.

Authors:  Anselm Mak
Journal:  World J Orthop       Date:  2014-01-18

3.  No differences in the efficacy among various core decompression modalities and non-operative treatment: a network meta-analysis.

Authors:  Byung-Ho Yoon; Young-Kyun Lee; Ki-Choul Kim; Yong-Chan Ha; Kyung-Hoi Koo
Journal:  Int Orthop       Date:  2018-05-31       Impact factor: 3.075

4.  Arthroscopic treatment of labral tears and concurrent avascular necrosis of the femoral head in young adults.

Authors:  David M Beck; Brian K Park; Thomas Youm; Theodore S Wolfson
Journal:  Arthrosc Tech       Date:  2013-09-23

5.  Osseoscopy: Direct Visualization to Assist Core Decompression and Debridement of Necrotic Bone Defects.

Authors:  William C Geisert; Aaron M Perdue; Kagan Ozer
Journal:  Arthrosc Tech       Date:  2017-05-15

6.  Comparison of core decompression and conservative treatment for avascular necrosis of femoral head at early stage: a meta-analysis.

Authors:  Yu-Cai Hong; Hui-Ming Zhong; Tiao Lin; Jian-Bin Shi
Journal:  Int J Clin Exp Med       Date:  2015-04-15

7.  Closed bone graft epiphysiodesis for avascular necrosis of the capital femoral epiphysis.

Authors:  George H Thompson; Ethan S Lea; Kenneth Chin; Raymond W Liu; Jochen P Son-Hing; Allison Gilmore
Journal:  Clin Orthop Relat Res       Date:  2013-07       Impact factor: 4.176

Review 8.  [Pain management in non-juvenile, aseptic osteonecrosis].

Authors:  M Jäger; A Werner; S Lentrodt; U Mödder; R Krauspe
Journal:  Schmerz       Date:  2004-12       Impact factor: 1.107

9.  Osteonecrosis of femoral head: Treatment by core decompression and vascular pedicle grafting.

Authors:  Sudhir Babhulkar
Journal:  Indian J Orthop       Date:  2009-01       Impact factor: 1.251

10.  Outcome after tantalum rod implantation for treatment of femoral head osteonecrosis: 26 hips followed for an average of 3 years.

Authors:  Sokratis E Varitimidis; Apostolos P Dimitroulias; Theophilos S Karachalios; Zoe H Dailiana; Konstantinos N Malizos
Journal:  Acta Orthop       Date:  2009-02       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.